key: cord-0750152-af5wfccj
authors: Cimolai, Nevio
title: Cerebral Microvascular and Macrovascular Disease Risk Factors and COVID-19 Progression
date: 2021-12-16
journal: Cerebrovasc Dis
DOI: 10.1159/000520901
sha: 5301996b1785ee593d394eb1a7ce5ae279b238d8
doc_id: 750152
cord_uid: af5wfccj

nan

Dear Editor, Nia et al. [1] proposed that past cerebrovascular disease history is an independent risk factor for enhanced COVID-19-related morbidity and mortality. The specific categorization of clinical entities that comprise cerebrovascular diseases in their research predominantly emphasizes preexisting macrovascular disease. In its greater breadth, cerebrovascular disease spans a more plenary spectrum of microvascular and/or macrovascular pathology [2, 3] . Is there any reason to believe that microvascular cerebral diseases are also risk factors for severity?

Chronic hypertension and its associated microvascular disease is lesser understood as among the spectrum of cerebrovascular diseases [4, 5] . Such pathology is initiated early in the course of chronic hypertension and may have a variable progressive pattern thereafter [6] . Given the latter, it would be tempting to hypothesize that such disease and its associated endotheliopathy may provide the right preconditions to complicate the thrombotic tendencies of active SARS-CoV-2 infection [7] . Both univariate and multivariate analyses have associated the precondition of hypertension with increased risk for more severe CO-VID-19 [8] [9] [10] . Systematic reviews also provide further corroboration for the latter [11, 12] . Also in pregnancy, hypertension associates with severity of infection [13] .

In this light, it would be of interest to determine if the data from Nia et al. [1] gives rise to similar findings for the association of hypertension and worse outcome. Moreover, it would be of value to determine if hypertension and the clinical macrovascular cerebrovascular diseases independently associate with worse COVID-19 or simply associate as co-variates. Such analyses have the potential to broaden our understanding of COVID-19-related endothelial disease for active infection, thrombosis, and potentially vaccine-related complications.

A history of cerebrovascular disease is independently associated with increased morbidity and mortality in patients with COVID-19: a cohort study

COVID-19 cases in the USA

Imprecise eponyms in stroke medicine: a growing need for uniform terminologies/definitions across the globe

Reader response: white matter hyperintensities mediate the association of nocturnal blood pressure with cognition. Neurology

Cerebrovascular disorders: a clinical and research classification

Cerebrovascular disease integration of chronic kidney disease and hypertension

Pathophysiology of Brain Damage in hypertension: small vessel disease

Untangling the intricacies of infection, thrombosis, vaccination, and antiphospholipid antibodies for COVID-19

A casecontrol analysis of stroke in COVID-19 patients: results of unusual manifestations of CO-VID-19 study

Association of cardiometabolic risk factors with hospitalization or death due to COVID-19: population-based cohort study in Sweden (SCAPIS)

Risk factors for hospitalization among persons with CO-VID-19: Colorado. PLoS One

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

Comparison of comorbidities in relation to critical conditions among Coronavirus Disease 2019 patients: a network meta-analysis. Infect Chemother

Maternal outcomes and risk factors for CO-VID-19 severity among pregnant women. Sci Rep